Your browser doesn't support javascript.
loading
LncRNA ANRIL promotes multiple myeloma progression and bortezomib resistance by EZH2-mediated epigenetically silencing of PTEN.
Yang, Li-Hui; Du, Peng; Liu, Wei; An, Li-Kun; Li, Jian; Zhu, Wen-Yi; Yuan, Shuo; Wang, Lei; Zang, Lei.
Afiliação
  • Yang LH; Department of Orthopedics, Beijing Chao-Yang Hospital, Beijing, China.
  • Du P; Department of Orthopedics, Beijing Chao-Yang Hospital, Beijing, China.
  • Liu W; Department of Orthopedics, Beijing Chao-Yang Hospital, Beijing, China.
  • An LK; Department of Orthopedics, Beijing Chao-Yang Hospital, Beijing, China.
  • Li J; Department of Orthopedics, Beijing Chao-Yang Hospital, Beijing, China.
  • Zhu WY; Department of Orthopedics, Beijing Chao-Yang Hospital, Beijing, China.
  • Yuan S; Department of Orthopedics, Beijing Chao-Yang Hospital, Beijing, China.
  • Wang L; Department of Orthopedics, Beijing Chao-Yang Hospital, Beijing, China.
  • Zang L; Department of Orthopedics, Beijing Chao-Yang Hospital, Beijing, China.
Neoplasma ; 68(4): 788-797, 2021 Jul.
Article em En | MEDLINE | ID: mdl-34034498

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: RNA Longo não Codificante / Mieloma Múltiplo Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: RNA Longo não Codificante / Mieloma Múltiplo Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article